Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A stage-specific traditional Chinese medicine (TCM) intervention developed by the Children's Hospital of Fudan University for the treatment of pediatric asthma. The regimen involves the use of the Shegan mixture during the acute phase of the disease and the Huangqi Bushen mixture (with symptom-based modifications) during the remission phase. This approach aims to manage symptoms and prevent recurrence by addressing different physiological states of the patient. In clinical trials, this herbal protocol is compared against standard Western treatments such as Salbutamol and Montelukast.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shegan mixture + Huangqi Bushen mixture.